Creative Planning Editas Medicine, Inc. Transaction History

Creative Planning

  • $101 Billion
  • Q3 2024

A detailed history of Creative Planning transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Creative Planning holds 21,563 shares of EDIT stock, worth $28,247. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,563
Previous 10,090 113.71%
Holding current value
$28,247
Previous $47,000 55.32%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
BUY
$3.39 - $5.96 $38,893 - $68,379
11,473 Added 113.71%
21,563 $73,000
Q2 2024

Aug 15, 2024
BUY
$4.67 - $7.28 $47,120 - $73,455
10,090 New
10,090 $47,000
Q2 2022

Aug 15, 2022
SELL
$9.99 - $21.35 $2,497 - $5,337
-250 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$14.08 - $27.63 $3,520 - $6,907
250 New
250 $5,000
Q3 2021

Nov 10, 2021
SELL
$39.27 - $72.94 $146,712 - $272,503
-3,736 Closed
0 $0
Q2 2021

Aug 04, 2021
SELL
$31.29 - $56.64 $416,125 - $753,255
-13,299 Reduced 78.07%
3,736 $212,000
Q1 2021

Apr 30, 2021
BUY
$39.71 - $90.58 $223,726 - $510,327
5,634 Added 49.42%
17,035 $715,000
Q4 2020

Jan 29, 2021
SELL
$27.07 - $84.35 $107,413 - $334,700
-3,968 Reduced 25.82%
11,401 $799,000
Q3 2020

Nov 05, 2020
SELL
$28.06 - $37.16 $785 - $1,040
-28 Reduced 0.18%
15,369 $431,000
Q2 2020

Jul 23, 2020
SELL
$18.5 - $34.34 $419,395 - $778,487
-22,670 Reduced 59.55%
15,397 $455,000
Q1 2020

May 05, 2020
SELL
$14.88 - $32.78 $186,074 - $409,913
-12,505 Reduced 24.73%
38,067 $755,000
Q4 2019

Jan 30, 2020
BUY
$19.49 - $32.63 $346,103 - $579,443
17,758 Added 54.12%
50,572 $1.5 Million
Q3 2019

Nov 01, 2019
SELL
$22.49 - $26.81 $16,867 - $20,107
-750 Reduced 2.23%
32,814 $746,000
Q2 2019

Jul 26, 2019
BUY
$20.48 - $27.76 $144,588 - $195,985
7,060 Added 26.64%
33,564 $830,000
Q1 2019

Apr 24, 2019
BUY
$19.43 - $26.41 $36,508 - $49,624
1,879 Added 7.63%
26,504 $648,000
Q4 2018

Feb 01, 2019
SELL
$18.19 - $31.79 $4,238 - $7,407
-233 Reduced 0.94%
24,625 $560,000
Q3 2018

Oct 25, 2018
BUY
$27.65 - $38.39 $774 - $1,074
28 Added 0.11%
24,858 $791,000
Q2 2018

Jul 20, 2018
SELL
$31.4 - $41.01 $38,527 - $50,319
-1,227 Reduced 4.71%
24,830 $890,000
Q1 2018

Apr 18, 2018
BUY
$29.84 - $44.08 $75,554 - $111,610
2,532 Added 10.76%
26,057 $864,000
Q4 2017

Jan 17, 2018
BUY
$21.89 - $31.34 $313,421 - $448,726
14,318 Added 155.51%
23,525 $723,000
Q3 2017

Oct 17, 2017
BUY
$15.81 - $24.01 $145,562 - $221,060
9,207
9,207 $221,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email